Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
The new pattern that investment grade companies will dare to issue bonds in the European market, even on days when stockmarkets are falling, was confirmed today when Anheuser-Busch InBev launched a three tranche bond that will be at least €4bn, while Volkswagen has brought the first car company bond since the crisis intensified, although it is from its financial services arm, which is backed by loans. -
New Development Bank, the Shanghai-based multilateral development bank, is planning to sell a Rmb5bn ($704m) Panda bond that will be used to provide an emergency loan to China.
-
Taiwanese banks have triggered a market disruption clause on a recent loan signed by Indonesian company BFI Finance. The move, which allows lenders to increase the margins they earn on deals, is being considered for numerous other transactions too, GlobalCapital Asia understands.
-
Mainland-based Kangji Medical Holdings is seeking approval to list in Hong Kong. It has filed an IPO application with the city’s bourse.
-
Emerging markets face at least $2.5tr of financing needs and do not possess the resources to fund themselves, said the IMF on Friday. But with bond markets continuing to improve and multilateral development banks increasing their firepower, prospects for EM funding are at least looking more promising than a week ago.
-
Standard Chartered will commit at least $1bn of financing for companies that provide goods and services that can be used to fight against the Covid-19 pandemic.
